
Microbiome Times


Phage lysin stabilizes vaginal microbiome: Phagomed accelerates R&D program against bacterial vaginosis.
Vienna-based biotech company PhagoMed Biopharma GmbH has discovered a novel drug candidate for the treatment of Bacterial Vaginosis and the re-stabilization of the vaginal microbiome. A dedicated R&D team has been established to develop this […]


Azitra Completes $14 Million Series A Financing
Azitra Inc., a clinical-stage medical dermatology company addressing serious skin conditions by harnessing the microbiome, today announced that it has closed a $14 million Series A financing. The financing was led by KdT Ventures in […]

BiomeSense Raises $2 Million in Seed Round Funding
BiomeSense, a microbiome startup developing a novel biosensor and analytics platform for daily gut microbiome tracking, announced today that it has closed its $2 million seed funding round. The lead investor was BioX Clan, which […]

Seventure Partners Life Sciences Corporate Update Health for Life: July 2019 – September 2019
Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment, is pleased to provide an update on its Health for Life investments for the period July 2019 to […]

Gut bacteria ‘fingerprint’ predicts radiotherapy side effects
Taking a ‘fingerprint’ of the mix of bacteria in the gut can indicate how susceptible individual cancer patients are to gut damage as a result of radiotherapy for prostate and gynaecological cancers, a new study […]

ORNL scientists shed light on microbial ‘dark matter’ with new approach
Scientists at the U.S. Department of Energy’s Oak Ridge National Laboratory have demonstrated a way to isolate and grow targeted bacteria using genomic data, making strides toward resolving the grand challenge of uncultivated microbial “dark […]

BASF and Biomillenia join forces in microbiome research to promote healthy skin
BASF and Biomillenia today announced the signing of a microbiome discovery agreement. The collaboration aims to identify novel dermocosmetic active ingredients involved in promoting skin health. The French company Biomillenia will contribute its unique microbiome-on-a-chip […]

4D Pharma collaborates with MSD to develop Live Biotherapeutics for vaccines
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces that the Company has entered into a research collaboration and option to license agreement with MSD, the tradename of […]

Researchers unlock potential to use CRISPR to alter the microbiome
Researchers at Western University have developed a new way to deliver the DNA-editing tool CRISPR-Cas9 into microorganisms in the lab, providing a way to efficiently launch a targeted attack on specific bacteria. Published in Nature […]